Zimmer Biomet to acquire iovera pain relief device from Pacira for up to $140M

Zimmer Biomet has agreed to pay up to $140 million to acquire Pacira BioSciences' iovera pain relief device, which uses extreme cold for targeted pain relief. The deal includes $70 million upfront and up to $70 million in milestones.

“The acquisition complements Zimmer’s existing product portfolio.”medtechdive.com

• 2 sources
• medtechdive.comZimmer to buy Pacira pain relief device for up to $140M | MedTech DiveElise ReuterJun 30, 2026
• medicaldevice-network.comZimmer to Acquire Pacira’s ioveraSalong DebbarmaJul 1, 2026

Summarized from public sources; check the original articles before acting on it.